Physician profile
Amirpasha Ehsan
NPI 1790073385
$1,237.04
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $271 · 2021: $238 · 2022: $316 · 2023: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Travel and Lodging: $9.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.31 |
| Travel and Lodging | $9.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $236.37 | 2021-2023 | Vapro Plus Pocket |
| Medtronic, INC. | $144.90 | 2022 | |
| Janssen Pharmaceuticals, INC | $137.55 | 2020 | |
| Flowonix Medical Incorporated | $133.62 | 2020 | |
| Lilly USA, LLC | $129.64 | 2023 | Taltz |
| Ucb, INC. | $125.00 | 2022 | |
| Radius Health, INC. | $118.21 | 2021 | |
| Neurometrix INC | $106.14 | 2023 | |
| Janssen Biotech, INC. | $33.96 | 2023 | Tremfya |
| Mallinckrodt Hospital Products INC. | $30.08 | 2023 | Acthar |
| Amgen INC. | $27.25 | 2021 | |
| Ibsa Pharma INC. | $14.32 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amirpasha Ehsan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.